These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37576338)

  • 21. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Leach MJ; Perez Algorta G
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention deficit in children with attention deficit hyperactivity disorder at primary school age measured with the attention network test (ANT): A protocol for a systematic review and meta-analysis.
    Gradys G; Lipowska M; Bieleninik Ł; Dzhambov AM
    PLoS One; 2022; 17(10):e0275599. PubMed ID: 36282809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.
    Lopez PL; Torrente FM; Ciapponi A; Lischinsky AG; Cetkovich-Bakmas M; Rojas JI; Romano M; Manes FF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010840. PubMed ID: 29566425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.
    Barnett T; Tollit M; Ratnapalan S; Sawyer SM; Kelaher M
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD011538. PubMed ID: 36752365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Efficacy of Physical Activity for Children with Attention Deficit Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Seiffer B; Hautzinger M; Ulrich R; Wolf S
    J Atten Disord; 2022 Mar; 26(5):656-673. PubMed ID: 34041952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Punja S; Shamseer L; Hartling L; Urichuk L; Vandermeer B; Nikles J; Vohra S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009996. PubMed ID: 26844979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions.
    Thabrew H; Stasiak K; Hetrick SE; Donkin L; Huss JH; Highlander A; Wong S; Merry SN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012488. PubMed ID: 30578633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of physical exercise on children with attention deficit hyperactivity disorders: Evidence through a meta-analysis.
    Zang Y
    Medicine (Baltimore); 2019 Nov; 98(46):e17980. PubMed ID: 31725664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Health Technol Assess; ; . PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.